Literature DB >> 29473734

Ligand Size and Conformation Affect the Behavior of Nanoparticles Coated with in Vitro and in Vivo Protein Corona.

Huajin Zhang, Tianmu Wu, Wenqi Yu, Shaobo Ruan, Qin He, Huile Gao.   

Abstract

Protein corona is immediately established on the surface of nanoparticles upon their introduction into biological milieu. Several studies have shown that the targeting efficiency of ligand-modified nanoparticles is attenuated or abolished owing to the protein adsorption. Here, transferrin receptor-targeting ligands, including LT7 (CHAIYPRH), DT7 (hrpyiahc, all d-form amino acids), and transferrin, were used to identify the influence of the ligand size and conformation on protein corona formation. The results showed that the targeting capacity of ligand-modified nanoparticles was lost after incubation with plasma in vitro, whereas it was partially retained after in vivo corona formation. Results from sodium dodecyl sulfate polyacrylamide gel electrophoresis and liquid chromatography-mass spectrometry revealed the difference in the composition of in vitro and in vivo corona, wherein the ligand size and conformation played a critical role. Differences were observed in cellular internalization and exocytosis profiles on the basis of the ligand and corona source.

Entities:  

Keywords:  T7 peptide; active targeting nanoparticle; cellular uptake; exocytosis; protein corona; proteomics; transferrin

Mesh:

Substances:

Year:  2018        PMID: 29473734     DOI: 10.1021/acsami.7b16096

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  25 in total

Review 1.  Engineering at the nano-bio interface: harnessing the protein corona towards nanoparticle design and function.

Authors:  Rebecca L Pinals; Linda Chio; Francis Ledesma; Markita P Landry
Journal:  Analyst       Date:  2020-07-01       Impact factor: 4.616

2.  Missing-in-metastasis protein promotes internalization of magnetic nanoparticles via association with clathrin light chain and Rab7.

Authors:  Peng Zhao; Bo Chen; Lushen Li; Hao Wu; Yan Li; Baxter Shaneen; Xi Zhan; Ning Gu
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-12-06       Impact factor: 3.770

3.  Changes in target ability of nanoparticles due to protein corona composition and disease state.

Authors:  Wenwen Xu; Mingyu Xu; Yumeng Xiao; Lu Yu; Huiru Xie; Xuehua Jiang; Meiwan Chen; Huile Gao; Ling Wang
Journal:  Asian J Pharm Sci       Date:  2022-04-04       Impact factor: 9.273

4.  Synthesis of a High Affinity Complementary Peptide-Polymer Nanoparticle (NP) Pair Using Phage Display.

Authors:  Shih-Hui Lee; Issa Moody; Zhiyang Zeng; Everly B Fleischer; Gregory A Weiss; Kenneth J Shea
Journal:  ACS Appl Bio Mater       Date:  2021-02-18

5.  Red blood cell-hitchhiking mediated pulmonary delivery of ivermectin: Effects of nanoparticle properties.

Authors:  Jinpeng Zheng; Caihong Lu; Yaning Ding; Jinbang Zhang; Fangyun Tan; Jingzhou Liu; Guobao Yang; Yuli Wang; Zhiping Li; Meiyan Yang; Yang Yang; Wei Gong; Chunsheng Gao
Journal:  Int J Pharm       Date:  2022-04-04       Impact factor: 6.510

6.  Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery.

Authors:  Lin Cui; Yuli Wang; Meng Liang; Xiaoyang Chu; Shiyao Fu; Chunsheng Gao; Qianqian Liu; Wei Gong; Meiyan Yang; Zhiping Li; Lian Yu; Chunrong Yang; Zhide Su; Xiangyang Xie; Yang Yang; Chunsheng Gao
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

7.  Effective Therapy Using a Liposomal siRNA that Targets the Tumor Vasculature in a Model Murine Breast Cancer with Lung Metastasis.

Authors:  Yu Sakurai; Tomoya Hada; Akari Kato; Yuta Hagino; Wataru Mizumura; Hideyoshi Harashima
Journal:  Mol Ther Oncolytics       Date:  2018-10-30       Impact factor: 7.200

Review 8.  The Application of Nanoparticle-Based Drug Delivery Systems in Checkpoint Blockade Cancer Immunotherapy.

Authors:  Huan Zhao; Yuanqi Li; Dan Wei; Hongrong Luo
Journal:  J Immunol Res       Date:  2018-09-30       Impact factor: 4.818

9.  Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles.

Authors:  Meng Liang; Chunhong Gao; Yuli Wang; Wei Gong; Shiyao Fu; Lin Cui; Zhenhan Zhou; Xiaoyang Chu; Yue Zhang; Qianqian Liu; Xiong Zhao; Baoquan Zhao; Meiyan Yang; Zhiping Li; Chunrong Yang; Xiangyang Xie; Yang Yang; Chunsheng Gao
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

Review 10.  Engineered Polymeric Materials for Biological Applications: Overcoming Challenges of the Bio-Nano Interface.

Authors:  Joshua D Simpson; Samuel A Smith; Kristofer J Thurecht; Georgina Such
Journal:  Polymers (Basel)       Date:  2019-09-02       Impact factor: 4.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.